If you are already a subscriber to this publication click here to read this item online in full.
If you wish to purchase the back-issue in which this item appeared, take a note of the Newsletter title and the month of publication and click here to visit the back-issues page from where you can order it.
Issue: September 2008, page: 4
ReGen Biologics raises funds, seeks approval for scaffold
Orthopaedics company ReGen Biologics Inc said it completed a US$2.5 million private placement of convertible notes and at the same time, submitted a new 510(k) application seeking clearance from the US Food and Drug Administration (FDA) of its collagen scaffold for reinforcement and repair of meniscus tissue.